Miopatia Necrotizante Induzida por Estatinas: Dois Casos Clínicos
Medicina Interna · 08.03.2023
DOI: 10.24950/rspmi.1718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina Interna, erschienen am 08.03.2023. Verfasst von Diana Isabel Rocha und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Statin-induced necrotizing myopathy is an immune-mediated adverse effect that, although rare, should be suspected in the presence of myalgia and rhabdomyolysis, which can persist even after discontinuation of the drug. The prognosis is generally favourable, requiring immunosuppressive therapy in most cases. We present two clinical cases with histological documentation, the second with greater severity requiring therapy with intravenous immunoglobulins. Statins are often prescribed for their role in reducing cardiovascular risk, so clinicians need to be aware of this entity so that treatment can be quickly started, preventing sequelae.
Schlagwörter
Zitieren
APA
Rocha, D. I., Ribeiro, F., Rui, Novo, & Ana (2023). Miopatia Necrotizante Induzida por Estatinas: Dois Casos Clínicos. Medicina Interna. https://doi.org/10.24950/rspmi.1718
Vancouver
Rocha DI, Ribeiro F, Rui, Novo, Ana. Miopatia Necrotizante Induzida por Estatinas: Dois Casos Clínicos. Medicina Interna. 2023. doi:10.24950/rspmi.1718
BibTeX
@article{Rocha2023,
author = {Rocha, Diana Isabel and Ribeiro, Flores and Rui and Novo and Ana},
title = {Miopatia Necrotizante Induzida por Estatinas: Dois Casos Clínicos},
journal = {Medicina Interna},
year = {2023},
doi = {10.24950/rspmi.1718}
}
EUVIMED